Stay updated with breaking news from Rose Weldon. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Five abstracts accepted for poster presentation at the Society for Immunotherapy of Cancer 2023 Annual Meeting Preliminary clinical biomarker data for anti-MICA/B antibody, CLN-619, supports proposed...
Phase 3 first-line study of zipalertinib in EGFR exon 20 insertion mutation non-small-cell lung cancer patients open to enrollment Initial monotherapy clinical data for CLN-619 presented at... -Today at 07:02 am- MarketScreener
/PRNewswire/ -- Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Cullinan Oncology, Inc., announced today the launch of the REZILIENT3 trial...
CLN-619 is a MICA/B directed humanized IgG1 antibody being studied in a global Phase 1 clinical trial in patients with advanced solid tumors. Initial...
CAMBRIDGE, Mass., Oct. 03, 2022 -- Cullinan Oncology, Inc. today announced that the compensation committee of the Company's Board of Directors granted stock option awards to purchase an... | October 3, 2022